会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Method for sustaining enos activity
    • 维持enos活动的方法
    • US20060127385A1
    • 2006-06-15
    • US10537599
    • 2003-12-04
    • Sibaji SarkarJane FreedmanSonia Varghese
    • Sibaji SarkarJane FreedmanSonia Varghese
    • A61K38/54
    • G01N33/86A61K31/05A61K31/27C12Q1/26G01N2333/90254
    • The present invention is directed to methods for sustaining eNOS activity to inhibit platelet aggregation, clot retraction, and enhance fibrinolysis. One embodiment of the invention provides methods of treating thrombosis by inhibiting the activity of the syk kinase. Another embodiment provides assays for the discovery of improved compounds to treat thrombosis, by screening for compounds which sustain eNOS activity. Yet another embodiment provides assays for the discovery of improved compounds to treat thrombosis, by identifying inhibitors of calpain and IIbIIIa by screening for compounds which act through calpain or IIbIIIa to sustain eNOS activity. Yet another embodiment provides for enhancing fibrinolysis, by inhibiting the activity of the syk kinase or calpain.
    • 本发明涉及维持eNOS活性以抑制血小板聚集,凝块缩回和增强纤维蛋白溶解的方法。 本发明的一个实施方案提供了通过抑制syk激酶的活性来治疗血栓形成的方法。 另一个实施方案提供了通过筛选维持eNOS活性的化合物来发现用于治疗血栓形成的改进化合物的测定。 另一个实施方案提供了通过筛选通过钙蛋白酶或IIbIIIa作用以维持eNOS活性的化合物来鉴定钙蛋白酶和IIbIIIa的抑制剂来发现治疗血栓形成的改进化合物的测定。 另一个实施方案通过抑制syk激酶或钙蛋白酶的活性来提供增强纤维蛋白溶解。
    • 2. 发明授权
    • Methods for identifying compounds for treatment of thrombotic condition
    • 鉴定用于治疗血栓形成症状的化合物的方法
    • US08586292B2
    • 2013-11-19
    • US12979753
    • 2010-12-28
    • Sibaji SarkarJane FreedmanSonia Varghese
    • Sibaji SarkarJane FreedmanSonia Varghese
    • C12Q1/00
    • G01N33/86A61K31/05A61K31/27C12Q1/26G01N2333/90254
    • The present invention is directed to methods for sustaining eNOS activity to inhibit platelet aggregation, clot retraction, and enhance fibrinolysis. One embodiment of the invention provides methods of treating thrombosis by inhibiting the activity of the syk kinase. Another embodiment provides assays for the discovery of improved compounds to treat thrombosis, by screening for compounds which sustain eNOS activity. Yet another embodiment provides assays for the discovery of improved compounds to treat thrombosis, by identifying inhibitors of calpain and IIbIIIa by screening for compounds which act through calpain or IIbIIIa to sustain eNOS activity. Yet another embodiment provides for enhancing fibrinolysis, by inhibiting the activity of the syk kinase or calpain.
    • 本发明涉及维持eNOS活性以抑制血小板聚集,凝块缩回和增强纤维蛋白溶解的方法。 本发明的一个实施方案提供了通过抑制syk激酶的活性来治疗血栓形成的方法。 另一个实施方案提供了通过筛选维持eNOS活性的化合物来发现用于治疗血栓形成的改进化合物的测定。 另一个实施方案提供了通过筛选通过钙蛋白酶或IIbIIIa作用以维持eNOS活性的化合物来鉴定钙蛋白酶和IIbIIIa的抑制剂来发现治疗血栓形成的改进化合物的测定。 另一个实施方案通过抑制syk激酶或钙蛋白酶的活性来提供增强纤维蛋白溶解。